Saturday , 1 October 2022

How Psychedelics Have Evolved Over the Last 6,000 Years

The graphic below is the first in a two-part series (see Part 2 here) that explores how psychedelics have evolved over the last 6,000 years.

Before we dive into the history of psychedelics, however, it’s important to understand what they are and how they work.

  • Psychedelics are drugs that alter cognitive processes and produce hallucinogenic effects. Broadly speaking,
    • there are two categories that psychedelic substances fall into: entheogens, and synthetic drugs. Entheogenic psychedelics are derived from plants, while synthetic psychedelics are created in a laboratory.

Psychedelic Substances Explained:

Here are some of the most well known:

history of psychedelics supplemental

Certain psychedelics work by binding to serotonin receptors in the brain which produces psychoactive effects. Research suggests that when this happens, the structure of the brain changes—such as the number of connections between neutrons. This means that psychedelics could have the potential to rewire or repair circuits in the brain, hence their reputation for having healing powers.

The following content is sponsored by Tryp Therapeutics.

The History of Psychedelics Infographic

In Part 2 of The History of Psychedelics, we’ll dive into The Psychedelics Renaissance the industry is currently experiencing and discuss the exciting future of this promising sector.

Editor’s Note:  The original post has been edited ([ ]) and abridged (…) above for the sake of clarity and brevity to ensure a fast and easy read.  The author’s views and conclusions are unaltered and no personal comments have been included to maintain the integrity of the original article.  Furthermore, the views, conclusions and any recommendations offered in this article are not to be construed as an endorsement of such by the editor. Also note that this complete paragraph must be included in any re-posting to avoid copyright infringement.

Related Articles from the munKNEE Vault

1. September Update on Performance of Marijuana & Psychedelic Compound-Based Drug Stocks

Which index out-performed in September, the munKNEE Pure-Play Marijuana-Based Drug Stocks Index or the munKNEE Pure-Play Psychedelic Compounds-Based Drug Stocks Index.? This article has the answer.

2. Which Psychedelic Stock ETF Is Right for You?

AdvisorShares Psychedelics ETF (Ticker: PSIL) began trading on the NYSE Acra exchange on Thursday, September 16th as the first U.S.-listed actively managed ETF to deliver dedicated investment exposure to psychedelics. All 5 are compared to help you decide which ETF to invest in or which ETF or Index to follow for the latest activity in the fledgling sector.

3. Interested In Cannabis & Psychedelic Stocks? Check Out These Sites

There are almost 100 relatively new sites available that cover various aspects of the fledgling but burgeoning cannabis and psychedelic markets but only 28 provide information of interest to current or potential investors.

4. 10 Psychedelic Substances Now Being Researched By 36 Companies

This article identifies the 10 psychedelic substances undergoing extensive research, those with the most therapeutic and commercial potential and the companies that are most involved in such research to help you decide which offer the best investment opportunities.

5. My “Magic” Mushroom Trip Was Absolutely Mind Blowing

Curious about the purported beneficial effects of psilocybin mushrooms on the mind, the writer decided to attend a guided hallucinogenic trip and found it to be the most important experience of his life.

6. The New “Psychedelic” Stocks ETF Is NOT As Advertised

The supposedly first and, supposedly, a “psychedelic” stocks ETF, was launched in the U.S. on May 27th. but it is not a true psychedelic stocks ETF nor is it the world’s first psychedelic ETF. This article uncovers what it really is.

7. The Psychedelic Renaissance Since 2017

This infographic tells the story behind the prohibition of psychedelic substances, and how strict regulations resulted in a hugely stigmatized industry.

A Few Last Words: 

  • Click the “Like” button at the top of the page if you found this article a worthwhile read as this will help us build a bigger audience.
  • Comment below if you want to share your opinion or perspective with other readers and possibly exchange views with them.
  • Register to receive our free Market Intelligence Report newsletter (sample here) in the top right hand corner of this page.
  • Join us on Facebook to be automatically advised of the latest articles posted and to comment on any of them. has joined to provide you with individual company research articles and specific stock recommendations in addition to munKNEE’s more general informative articles on the economy, the markets, and gold, silver and cannabis investing.
Check out eResearch. If you like what you see then…